Table 4.
Univariate tests of significance (ANCOVA)
| Univariate tests of significance (ANCOVA) | ||||
|---|---|---|---|---|
| Observations | Dependent variables (pre–post Δ) | Categorical predictors (ΔIF vs ΔND) | Covariates (baseline values) | P values |
| Body weight | −0.40 ± 1.76 | −0.97 ± 1.58 vs 0.16 ± 1.78 | 84.63 ± 6.17 | 0.0354 |
| FM (kg) | −0.96 ± 1.72 | −1.61 ± 1.53 vs −0.30 ± 1.70 | 11.12 ± 3.98 | 0.0070 |
| Adiponectin (μg/mL) | −0.45 ± 3.07 | 2.04 ± 1.52 vs −2.94 ± 1.97 | 12.83 ± 1.98 | 0.0000 |
| Leptin (ng/mL) | 0.09 ± 0.67 | −0.36 ± 0.31 vs 0.54 ± 0.64 | 1.97 ± 0.52 | 0.0000 |
| IL-6 (ng/L) | −0.15 ± 0.27 | −0.25 ± 0.30 vs −0.04 ± 0.20 | 1.28 ± 0.31 | 0.0378 |
| TNF-α (ng/L) | −0.14 ± 0.47 | −0.45 ± 0.37 vs 0.17 ± 0.34 | 5.63 ± 0.83 | 0.0000 |
| IL-1β (ng/L) | −0.05 ± 0.14 | −0.12 ± 0.15 vs 0.02 ± 0.09 | 0.92 ± 0.15 | 0.0000 |
| Testosterone total (nmol/L) | −2.07 ± 3.60 | −4.40 ± 3.02 vs 0.25 ± 2.43 | 19.93 ± 6.00 | 0.0000 |
| IGF-1 (ng/mL) | −12.38 ± 33.04 | −28.00 ± 40.11 vs 3.23 ± 11.13 | 216.32 ± 38.84 | 0.0003 |
The Δ pre–post for each depended variable group were considered and the baseline values of the outcomes were adopted as covariate; TRF vs ND were assumed as categorical predictors